Healthcare provider profile · identity verified

Travis C Willow, NP-C

Nurse Practitioner · RED LION, PA · NPI 1396385217

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	301	115
Lisinopril	Lisinopril	204	85
Amlodipine Besylate	Amlodipine Besylate	164	58
Omeprazole	Omeprazole	121	43
Albuterol Sulfate Hfa	Albuterol Sulfate	117	47
Metoprolol Succinate	Metoprolol Succinate	117	42
Gabapentin	Gabapentin	104	34
Rosuvastatin Calcium	Rosuvastatin Calcium	99	45
Tamsulosin Hcl	Tamsulosin Hcl	94	27
Simvastatin	Simvastatin	92	36
Levothyroxine Sodium	Levothyroxine Sodium	89	42
Pantoprazole Sodium	Pantoprazole Sodium	88	25
Metformin Hcl	Metformin Hcl	84	33
Losartan Potassium	Losartan Potassium	81	35
Prednisone	Prednisone	81	71
Furosemide	Furosemide	75	29
Hydrochlorothiazide	Hydrochlorothiazide	75	37
Sertraline Hcl	Sertraline Hcl	65	25
Fluticasone Propionate	Fluticasone Propionate	61	34
Trazodone Hcl	Trazodone Hcl	61	19
Duloxetine Hcl	Duloxetine Hcl	58	17
Eliquis	Apixaban	55	18
Metoprolol Tartrate	Metoprolol Tartrate	53	18
Meloxicam	Meloxicam	52	20
Metformin Hcl Er	Metformin Hcl	52	21
Glipizide Er	Glipizide	48	21
Pravastatin Sodium	Pravastatin Sodium	46	19
Quetiapine Fumarate	Quetiapine Fumarate	46	11
Ropinirole Hcl	Ropinirole Hcl	44	12
Famotidine	Famotidine	43	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	24
Jardiance	Empagliflozin	39	13
Azithromycin	Azithromycin	36	33
Carvedilol	Carvedilol	31	12
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	29
Montelukast Sodium	Montelukast Sodium	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	28
Methylprednisolone	Methylprednisolone	29	29
Bupropion Xl	Bupropion Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	11
Synthroid	Levothyroxine Sodium	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	24
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Atenolol	Atenolol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Topiramate	Topiramate	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amoxicillin	Amoxicillin	18	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Cephalexin	Cephalexin	14	14
Enalapril Maleate	Enalapril Maleate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Valsartan	Valsartan	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Alprazolam	Alprazolam	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Finasteride	Finasteride	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ozempic	Semaglutide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error